The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4+Foxp3+ Regulatory T Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4+Foxp3+ Regulatory T Cells
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-07-09
DOI
10.3389/fimmu.2018.01556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF-β1/Smad2/3/Foxp3 signaling is required for chronic stress-induced immune suppression
- (2018) Haiju Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Death receptor 3 signaling enhances proliferation of human regulatory T cells
- (2017) Sebastian Bittner et al. FEBS LETTERS
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
- (2017) Xin Chen et al. Science Signaling
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
- (2017) Xin Chen et al. Science Signaling
- Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
- (2017) Ping Li et al. Frontiers in Pharmacology
- TNF-α priming enhances CD4 + FoxP3 + regulatory T-cell suppressive function in murine GVHD prevention and treatment
- (2016) Antonio Pierini et al. BLOOD
- Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells
- (2016) M. Leclerc et al. BLOOD
- Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction
- (2016) Morisada Hayakawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
- (2016) Martin Chopra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF–TNF-RII binding in rheumatoid arthritis
- (2016) Dao Xuan Nguyen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Suppressive activity of human regulatory T cells is maintained in the presence of TNF
- (2016) Bruno Zaragoza et al. NATURE MEDICINE
- TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment
- (2016) Meng Wu et al. Oncotarget
- Inducing and Administering Tregs to Treat Human Disease
- (2016) Ana Luisa Perdigoto et al. Frontiers in Immunology
- Aminopeptidase P3, a new member of the TNF-TNFR2 signaling complex, induces phosphorylation of JNK1 and JNK2
- (2015) M. Inoue et al. JOURNAL OF CELL SCIENCE
- Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion
- (2015) Li-Yuan Chang et al. OncoImmunology
- Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics
- (2014) A. G. Jarnicki et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells
- (2014) X. Chen et al. JOURNAL OF IMMUNOLOGY
- p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression
- (2014) Yong Lu et al. Nature Communications
- CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy
- (2013) Caspar Kühnöl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases
- (2013) H. Patterson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- In vitro generated Th17 cells support the expansion and phenotypic stability of CD4+Foxp3+ regulatory T cells in vivo
- (2013) Qiong Zhou et al. CYTOKINE
- The anti-inflammatory compound BAY-11-7082 is a potent inhibitor of protein tyrosine phosphatases
- (2013) Navasona Krishnan et al. FEBS Journal
- TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment
- (2013) X. Chen et al. JOURNAL OF IMMUNOLOGY
- IL-2-Independent and TNF- -Dependent Expansion of V 5+ Natural Regulatory T Cells during Retrovirus Infection
- (2013) L. Myers et al. JOURNAL OF IMMUNOLOGY
- Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules
- (2013) Takanori So et al. Frontiers in Immunology
- Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis
- (2011) R. Noubade et al. BLOOD
- TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40
- (2011) Ryoko Hamano et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor necrosis factor α blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells
- (2010) Hak-Ling Ma et al. ARTHRITIS AND RHEUMATISM
- Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
- (2010) D. Mougiakakos et al. BLOOD
- MAP kinase p38 and its relation to T cell anergy and suppressor function of regulatory T cells
- (2010) Henric S. Adler et al. CELL CYCLE
- Targeted inhibition of IL-10-secreting CD25−Tregviap38 MAPK suppression in cancer immunotherapy
- (2010) Kozo Ohkusu-Tsukada et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+regulatory T cells in human peripheral blood
- (2010) Xin Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Acquisition of regulatory function by human CD8+ T cells treated with anti-CD3 antibody requires TNF
- (2010) Vitaly Ablamunits et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs
- (2010) Yenkel Grinberg-Bleyer et al. JOURNAL OF CLINICAL INVESTIGATION
- TNF Activates a NF- B-Regulated Cellular Program in Human CD45RA- Regulatory T Cells that Modulates Their Suppressive Function
- (2010) M. Nagar et al. JOURNAL OF IMMUNOLOGY
- Expression of Costimulatory TNFR2 Induces Resistance of CD4+FoxP3- Conventional T Cells to Suppression by CD4+FoxP3+ Regulatory T Cells
- (2010) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Critical Role for TNF in the Induction of Human Antigen-Specific Regulatory T Cells by Tolerogenic Dendritic Cells
- (2010) F. S. Kleijwegt et al. JOURNAL OF IMMUNOLOGY
- TNF receptor 2 pathway: drug target for autoimmune diseases
- (2010) Denise Faustman et al. NATURE REVIEWS DRUG DISCOVERY
- Modulation of p38 MAPK Activity in Regulatory T Cells after Tolerance with Anti-DNA Ig Peptide in (NZB x NZW)F1 Lupus Mice
- (2009) E. V. Lourenco et al. JOURNAL OF IMMUNOLOGY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25− T Cells into iTreg
- (2008) Samuel Huber et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started